Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
49 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Ferring International Center S.A. - Product Pipeline Review - 2016 Summary
Global Markets Direct's, 'Ferring International Center S.A. - Product Pipeline Review - 2016', provides an overview of the Ferring International Center S.A.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Ferring International Center S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Ferring International Center S.A. - The report provides overview of Ferring International Center S.A. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Ferring International Center S.A.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Ferring International Center S.A.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to buy
- Evaluate Ferring International Center S.A.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Ferring International Center S.A. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Ferring International Center S.A.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 5 Ferring International Center S.A. Snapshot 6 Ferring International Center S.A. Overview 6 Key Information 6 Key Facts 6 Ferring International Center S.A. - Research and Development Overview 7 Key Therapeutic Areas 7 Ferring International Center S.A. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 Pipeline Products - Out-Licensed Products 13 Out-Licensed Products/Combination Treatment Modalities 14 Ferring International Center S.A. - Pipeline Products Glance 15 Ferring International Center S.A. - Late Stage Pipeline Products 15 Pre-Registration Products/Combination Treatment Modalities 15 Phase III Products/Combination Treatment Modalities 16 Ferring International Center S.A. - Clinical Stage Pipeline Products 17 Phase II Products/Combination Treatment Modalities 17 Ferring International Center S.A. - Early Stage Pipeline Products 18 Preclinical Products/Combination Treatment Modalities 18 Ferring International Center S.A. - Drug Profiles 19 follitropin delta 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Testavan 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 degarelix acetate 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 elobixibat 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 selepressin 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 barusiban 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 carbetocin 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 FE-999301 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 merotocin 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 FE-201874 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 FE-204038 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 FE-999310 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Small Molecule for Undisclosed Indication 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Ferring International Center S.A. - Pipeline Analysis 34 Ferring International Center S.A. - Pipeline Products by Target 34 Ferring International Center S.A. - Pipeline Products by Route of Administration 35 Ferring International Center S.A. - Pipeline Products by Molecule Type 36 Ferring International Center S.A. - Pipeline Products by Mechanism of Action 37 Ferring International Center S.A. - Recent Pipeline Updates 38 Ferring International Center S.A. - Dormant Projects 41 Ferring International Center S.A. - Discontinued Pipeline Products 42 Discontinued Pipeline Product Profiles 42 DR-2011 42 Ferring International Center S.A. - Locations and Subsidiaries 43 Head Office 43 Other Locations & Subsidiaries 43 Appendix 48 Methodology 48 Coverage 48 Secondary Research 48 Primary Research 48 Expert Panel Validation 48 Contact Us 48 Disclaimer 49
List of Tables
Ferring International Center S.A., Key Information 6 Ferring International Center S.A., Key Facts 6 Ferring International Center S.A. - Pipeline by Indication, 2016 8 Ferring International Center S.A. - Pipeline by Stage of Development, 2016 9 Ferring International Center S.A. - Monotherapy Products in Pipeline, 2016 10 Ferring International Center S.A. - Partnered Products in Pipeline, 2016 11 Ferring International Center S.A. - Partnered Products/ Combination Treatment Modalities, 2016 12 Ferring International Center S.A. - Out-Licensed Products in Pipeline, 2016 13 Ferring International Center S.A. - Out-Licensed Products/ Combination Treatment Modalities, 2016 14 Ferring International Center S.A. - Pre-Registration, 2016 15 Ferring International Center S.A. - Phase III, 2016 16 Ferring International Center S.A. - Phase II, 2016 17 Ferring International Center S.A. - Preclinical, 2016 18 Ferring International Center S.A. - Pipeline by Target, 2016 34 Ferring International Center S.A. - Pipeline by Route of Administration, 2016 35 Ferring International Center S.A. - Pipeline by Molecule Type, 2016 36 Ferring International Center S.A. - Pipeline Products by Mechanism of Action, 2016 37 Ferring International Center S.A. - Recent Pipeline Updates, 2016 38 Ferring International Center S.A. - Dormant Developmental Projects,2016 41 Ferring International Center S.A. - Discontinued Pipeline Products, 2016 42 Ferring International Center S.A., Other Locations 43 Ferring International Center S.A., Subsidiaries 44
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.